+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars And Biosuperiors Market Research Reports

United States Biosimilars Market Report and Forecast 2025-2034 - Product Thumbnail Image

United States Biosimilars Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 250 Pages
  • United States
From
Middle East & Africa Biosimilars Market Outlook, 2030 - Product Thumbnail Image

Middle East & Africa Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 80 Pages
  • Middle East, Africa
From
Asia-Pacific Biosimilars Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 95 Pages
  • Asia Pacific
From
Europe Biosimilars Market Outlook, 2030 - Product Thumbnail Image

Europe Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 96 Pages
  • Europe
From
North America Biosimilars Market Outlook, 2030 - Product Thumbnail Image

North America Biosimilars Market Outlook, 2030

  • Report
  • May 2025
  • 87 Pages
  • North America
From
From
From
Biosimilar Monoclonal Antibodies Market Report 2022-2032 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Market Report 2022-2032

  • Report
  • July 2022
  • 461 Pages
  • Global
From
From
From
From
Aflibercept (Eylea) Biosimilars Pipeline Review - Product Thumbnail Image

Aflibercept (Eylea) Biosimilars Pipeline Review

  • Report
  • August 2025
  • Global
From
From
Adalimumab (Humira) Biosimilars Pipeline Review - Product Thumbnail Image

Adalimumab (Humira) Biosimilars Pipeline Review

  • Report
  • August 2025
  • Global
From
From
From
US Biosimilar Market: Insights & Forecast (2024-2028) - Product Thumbnail Image

US Biosimilar Market: Insights & Forecast (2024-2028)

  • Report
  • August 2024
  • 72 Pages
  • United States
From
From
Loading Indicator

The Biosimilars and Biosuperiors market is a rapidly growing sector of the pharmaceutical industry. Biosimilars are biologic drugs that are highly similar to an existing biologic drug, while biosuperiors are biologic drugs that are more effective than an existing biologic drug. Biosimilars and biosuperiors are used to treat a variety of conditions, including cancer, autoimmune diseases, and inflammatory diseases. Biosimilars and biosuperiors are developed using advanced biotechnology techniques, such as recombinant DNA technology and monoclonal antibody technology. These drugs are designed to be more cost-effective than their original counterparts, while still providing the same therapeutic benefits. The Biosimilars and Biosuperiors market is expected to continue to grow in the coming years, as more biologic drugs are developed and approved for use. Companies in this market include Amgen, Pfizer, Merck, and Novartis. Show Less Read more